Curis Inc
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CRIS Company Description
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
CRIS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CRIS Smart Score
Score Breakdown
CRIS Company Description
Show More
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CRIS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CRIS's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on CRIS's company Twitter account
WallStreetBets
Number of mentions of CRIS in WallStreetBets Daily Discussion
CRIS News
Recent insights relating to CRIS
CNBC Recommendations
Recent picks made for CRIS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CRIS
Corporate Flights
Flights by private jets registered to CRIS
Our Analysis